Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2147/JIR.S257078 http://scihub22266oqcxt.onion/10.2147/JIR.S257078 32669866!7335895!32669866     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Inflamm+Res 2020 ; 13 (ä): 285-292 Nephropedia Template TP {{tp|p=32669866|t=2020. Alteration of Liver Biomarkers in Patients with SARS-CoV-2 (COVID-19) |pdf=|usr=}}{{32669866}} gab.com Text Alteration of Liver Biomarkers in Patients with SARS-CoV-2 (COVID-19) JO: J Inflamm Res http://www.kidney.de/pget.php?&tw=1&pmid=32669866 #FOAvip INTRODUCTION: Coronavirus disease 2019 (COVID-19) emerged in China and spread worldwide. In this study, we assessed the characteristics of markers of the liver in patients with COVID-19 to provide new insights in improving clinical treatment. PATIENTS AND METHODS: We recruited 279 patients who confirmed COVID-19 and the data of liver biomarkers and complete blood count of patients were defined as the day onset when the patients admitted to the hospital. RESULTS: The average of LDH value was 621.29 U/L in all patients with COVID-19, and CPK was 286.90 U/L. The average AST was 44.03 U/L in all patients, and ALT was 31.14 U/L. The AST/ALT ratio was 1.64 in all patients. The measurement of CRP was increased by 79.93% in all patients. Average ALT and AST values of patients with elevated ALT were significantly increased in comparison to patients with normal ALT (P-value = 0.001), while AST/ALT ratio was significantly decreased compared to patients with normal ALT (P-value= 0.014). In addition, the average LDH of patients with elevated ALT was significantly increased compared to patients with normal ALT (P-value = 0.014). CONCLUSION: Hepatic injury and abnormal liver enzymes related to COVID-19 infection is an acute non-specific inflammation alteration. Twit Text FOAVip Alteration of Liver Biomarkers in Patients with SARS-CoV-2 (COVID-19) ????J Inflamm Res http://www.kidney.de/pget.php?&tw=1&pmid=32669866 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32669866 #FOAvip English Wikipedia <ref>{{Cite pmid|32669866}}</ref> Alteration of Liver Biomarkers in Patients with SARS-CoV-2 (COVID-19) #MMPMID32669866 Gholizadeh P; Safari R; Marofi P; Zeinalzadeh E; Pagliano P; Ganbarov K; Esposito S; Khodadadi E; Yousefi M; Samadi Kafil H J Inflamm Res 2020[]; 13 (ä): 285-292 PMID32669866show ga INTRODUCTION: Coronavirus disease 2019 (COVID-19) emerged in China and spread worldwide. In this study, we assessed the characteristics of markers of the liver in patients with COVID-19 to provide new insights in improving clinical treatment. PATIENTS AND METHODS: We recruited 279 patients who confirmed COVID-19 and the data of liver biomarkers and complete blood count of patients were defined as the day onset when the patients admitted to the hospital. RESULTS: The average of LDH value was 621.29 U/L in all patients with COVID-19, and CPK was 286.90 U/L. The average AST was 44.03 U/L in all patients, and ALT was 31.14 U/L. The AST/ALT ratio was 1.64 in all patients. The measurement of CRP was increased by 79.93% in all patients. Average ALT and AST values of patients with elevated ALT were significantly increased in comparison to patients with normal ALT (P-value = 0.001), while AST/ALT ratio was significantly decreased compared to patients with normal ALT (P-value= 0.014). In addition, the average LDH of patients with elevated ALT was significantly increased compared to patients with normal ALT (P-value = 0.014). CONCLUSION: Hepatic injury and abnormal liver enzymes related to COVID-19 infection is an acute non-specific inflammation alteration. äAlteration of Liver Biomarkers in Patients with SARS-CoV-2 (COVID-19) (epmc).pdf DeepDyve Pubget Overpricing